Table 1 Patient and tumour characteristics.
Characteristics | Total (n = 28) | Locally advanced (n = 22) | Metastatic (n = 6) |
p16 IHC status | |||
Positive | 23 (82%) | 18 (82%) | 5 (83%) |
Negative | 5 (18%) | 4 (18%) | 1 (17%) |
Age | |||
Median (range) years | 63 (46–78) | 64 (46–78) | 62 (54–64) |
Gender | |||
Female | 2 (7%) | 0 (0%) | 2 (33%) |
Male | 26 (93%) | 22 (100%) | 4 (67%) |
Race | |||
Caucasian | 28 (100%) | 28 (100%) | 28 (100%) |
Other | 0 (0%) | 0 (0%) | 0 (0%) |
Stage (7th AJCC edition) | |||
III | 2 (7%) | 2 (9%) | 0 (0%) |
IVA | 18 (64%) | 18 (82%) | 0 (0%) |
IVB | 2 (7%) | 2 (9%) | 0 (0%) |
IVC | 6 (22%) | 0 (0%) | 6 (100%) |
Smoking or tobacco use | |||
Ex-smoker | 11 (39%) | 8 (36.5%) | 3 (50%) |
Current smoker | 7 (25%) | 6 (27%) | 1 (17%) |
Non-smoker | 10 (36%) | 8 (36.5%) | 2 (33%) |